[Serum phospholipase A2 activity in osteoarthritis].
Serum phospholipase A2 activity in 67 osteoarthritis patients and 17 controls was determined using a radiolabeled specific substrate. Serum phospholipase A2 activity was significantly higher in osteoarthritis patients (115 +/- 73.6 dpm/h/ml) than in controls (45 +/- 25 dpm/h/ml) (p = 0.002). In 41 osteoarthritis patients, serum phospholipase A2 activity was unrelated to age, time since onset of osteoarthritis symptoms, duration of morning stiffness, Lequesne's index, roentgenographic stage of osteoarthritis, number of joints with osteoarthritis, erythrocyte sedimentation rate, or serum C-reactive protein levels. In 12 osteoarthritis patients who were evaluated twice at a mean interval of 46 days, changes in serum phospholipase A2 activity were unrelated to changes in Lequesne's index. Blind evaluation of long-term joint space loss was performed in 14 patients; serum phospholipase A2 activity increased only in those patients with progressive joint space loss, but the difference was not statistically significant as compared with the controls. These data suggest that serum phospholipase A2 activity is not useful in practice as a marker for osteoarthritis.
Balblanc
J C
JC
Laboratoire d'Exploration Articulaire, Hôpital Edouard Herriot, Lyon.
Conrozier
T
T
Mathieu
P
P
Tron
A M
AM
Broquet
P
P
Piperno
M
M
Richard
M
M
Vignon
E
E
D000328:Adult; D015415:Biomarkers; D005260:Female; D006801:Humans; D007719:Knee Joint; D008297:Male; D010003:Osteoarthritis / Q000097:blood / Q000201:enzymology*; D015207:Osteoarthritis, Hip / Q000097:blood / Q000201:enzymology; D010741:Phospholipases A / Q000097:blood / Q000378:metabolism*; D054467:Phospholipases A2; D011446:Prospective Studies; D012720:Severity of Illness Index; D013997:Time Factors
D015415:Biomarkers; D010741:Phospholipases A; D054467:Phospholipases A2
L'activité sérique de la phospholipase A2 dans l'arthrose.